NEWS・COLUMN
We send the latest information from SMC Laboratories.
Acute Liver Failure Mouse Model Lineup
Acute liver failure (ALF) carries a high mortality of approximately 40%, which is caused by virus infections (…
New Service: In Vitro Assay for Fibrosis Evaluation
We are delighted to announce the launch of our new in vitro assay service for fibrosis evaluation.  …
Introducing our new pulmonary fibrosis model: Silica-induced pulmonary fibrosis model
Today, we are pleased to announce that we have expanded our preclinical model lineup by including the “S…
Introduction of Inflammatory Bowel Disease mouse model
Today, we give you a brief introduction to the dextran sulfate sodium (DSS) -induced colitis model, which is a…
Introduction of chronic kidney disease mice models
I am writing you today to share some information on our Chronic kidney disease (CKD) models. CKD is a c…
Introduction of NASH model with high clinical correlation
Non-alcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases worldwide. Around t…
Introduction of bleomycin-induced SSc-ILD model
Today, we would like to introduce a more clinically correlative model in which skin and lung fibrosis develop …
Introduction of positive control drug for kidney fibrosis mouse model
Today, we would like to introduce an established positive control – an ALK5 inhibitor – for our Un…
Introduction of our experiences in histopathological analyses for IPF
Today, we present some new histopathological data from our bleomycin-induced pulmonary fibrosis model, which i…
Introduction of STAM™ model for pre-clinical studies for liver cancer
Today, we give you a brief introduction to our proprietary NASH-HCC model (STAM™ model). The STAM™…
Introducing our new skin disease model: Imiquimod (IMQ)-induced psoriasis model
We are pleased to announce that we have expanded our preclinical model lineup by including the “Imiquimo…
Introduction of our Primary sclerosing cholangitis (PSC) mice model
Today, I would like to give you a brief introduction into primary sclerosing cholangitis (PSC), as well as our…